MEDICINES CO's ticker is and the CUSIP is 584688AC9. A total of 28 filers reported holding MEDICINES CO in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $306,000 | -8.1% | 232,000 | 0.0% | 0.04% | -15.1% |
Q3 2016 | $333,000 | -25.0% | 232,000 | -30.1% | 0.05% | -29.3% |
Q2 2016 | $444,000 | -76.5% | 332,000 | -77.6% | 0.08% | -77.0% |
Q1 2016 | $1,887,000 | -10.7% | 1,485,000 | 0.0% | 0.33% | -13.3% |
Q4 2015 | $2,113,000 | -33.6% | 1,485,000 | -32.0% | 0.38% | -17.9% |
Q3 2015 | $3,181,000 | +19.6% | 2,185,000 | -2.2% | 0.46% | +45.4% |
Q2 2015 | $2,660,000 | -46.6% | 2,235,000 | -46.8% | 0.32% | -16.0% |
Q1 2015 | $4,980,000 | – | 4,200,000 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 2,773,648 | $94,138,000 | 90.87% |
DLD Asset Management, LP | 8,878,000 | $12,240,000 | 4.01% |
Worth Venture Partners, LLC | 1,864 | $2,518,000 | 2.69% |
TFG Asset Management GP Ltd | 7,210,000 | $9,652,000 | 1.92% |
MACKAY SHIELDS LLC | 7,145,000 | $9,463,000 | 0.45% |
PALISADE CAPITAL MANAGEMENT, LP | 5,897,000 | $8,155,000 | 0.31% |
CSS LLC/IL | 980,000 | $1,313,000 | 0.07% |
PROSPECTOR PARTNERS LLC | 232,000 | $306,000 | 0.04% |
Allianz Asset Management GmbH | 15,815,000 | $21,724,000 | 0.02% |
Citadel Advisors | 8,345,000 | $11,075,000 | 0.01% |